Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML - HSA Drug Approval Details

Approvals/HSA/MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML

Approved

THERAPEUTIC

MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML

MEDOCHEMIE LTD - FACTORY B (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Jan 20, 1999
Approval ID: c1975b69fe2dacbd
Company: MEDOCHEMIE LTD - FACTORY B (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: c1975b69fe2dacbd
Drug Name: MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML
Product Name: MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML
Approval Number: SIN10687P
Approval Date: 1999-01-20
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder: MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: POWDER, FOR SUSPENSION
Route Of Administration: ORAL
Atc Code: J01CR02
Atc Item Name: amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name: MEDOCHEMIE SINGAPORE PTE. LTD.

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg/5 ml

CLAVULANATE POTASSIUM EQV CLAVULANIC ACID

62.5 mg/5 ml

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg/5 ml

CLAVULANATE POTASSIUM EQV CLAVULANIC ACID

62.5 mg/5 ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 20, 1999

Approval ID

c1975b69fe2dacbd

Type

Therapeutic

Back to HSA Approvals